|Universal LV transduction enhancer.|
Read about LentiBOOSTTM in the news.
LentiBOOSTTM is a highly effective, non-cytotoxic chemical transduction enhancer. As universal adjuvant acting cell receptor independent it can be applied to a wide range of cell types from hard to transduce cancer cell lines up to challenging primary cells. Strongest enhancing effects have been observed on clinically relevant cell types including CD34+ hematopoietic stem cells (HSCs) and primary T-cells. These unique features make it a promising candidate to improve clinical transduction protocols for ex vivo gene therapies.
Available in two grades;
LentiBOOSTTM research grade
for basic research applications, available to academic groups.
LentiBOOSTTM clinical grade
available as GMP material for use in
clinical stage protocols. Licensing options for Commercial
Use and Development are available. Please inquire with email@example.com.
Combination of LentiBOOSTTM and spinocculation protocols greatly improves Lentiviral application.
·Increase transduction,up to 90%even in hematopoetic cells
·Access to a broader range of cell types
·No cell toxicity
·Ready to be integrated in clinical development
CONTACT US to learn how this adjuvant can help improve your research.